Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1699228

registered interest
date	26/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Research
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government whether they will establish targeted funding to prioritise and drive research investment into pancreatic cancer and the other less survivable cancers.
tabling member printed	Lord Hunt of Kings Heath
uin	HL3618
answer	answer is ministerial correction date of answer 08/04/2024 answer text <p>Research is crucial in the fight against cancer, which is why the Department invests £1 billion per year in health research through the National Institute for Health and Care Research (NIHR). NIHR research expenditure for all cancers was £121 million for 2022/23.</p><p>In terms of establishing targeted funding into pancreatic cancer, the NIHR funds research in response to proposals received from scientists rather than allocating funding to specific disease areas. It is not usual practice to ring-fence funds for particular topics or conditions. Applications are subject to peer review and judged in open competition, with awards made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality.</p><p>The Government, through the NIHR, is committed to improving research into pancreatic cancer and cancers with the poorest survival rates by funding high quality, timely research that leads to improved outcomes for patients and the public, and makes the health and social care system more efficient, effective, and safe. Research evidence is vital for improving treatments and outcomes for people, including those with pancreatic cancer and other less survivable cancers.</p><p>In 2023, the Government awarded £2 million to new interdisciplinary research teams tackling hard to treat cancers, via the Medical Research Council, which hosted a two-day cancer sandpit strategic funding opportunity, focused on technological innovation for understanding cancers with the poorest survival rates.</p><p>The NIHR has funded seven research projects for pancreatic cancer for the period 2019 to 2023, with a total committed spend of approximately £3.6 million. The NIHR also supports the delivery of pancreatic cancer research funded by those in the charity and public sectors. For example, since 2019, the NIHR Clinical Research Network has supported over 70 pancreatic cancer-related studies.</p><p>The NIHR continues to encourage and welcome applications for research into any aspect of human health, including pancreatic cancer. All applications are assessed for funding by peer review committees. The level of research spend in a particular area is driven by factors including the quality of the proposals and their scientific potential. All applications for research into pancreatic cancer and other less survivable cancers made through open competition have been funded.</p> answering member printed Lord Markham grouped question UIN HL3619 question first answered 08/04/2024 11:25:36 answering member 4948 label Biography information for Lord Markham
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1699229

registered interest
date	26/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Research
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government whether they will encourage the National Institute for Health and Care Research to rigorously evaluate existing research efforts and review how they can further prioritise and drive research investment for pancreatic cancer and other less survivable cancers.
tabling member printed	Lord Hunt of Kings Heath
uin	HL3619
answer	answer is ministerial correction date of answer 08/04/2024 answer text <p>Research is crucial in the fight against cancer, which is why the Department invests £1 billion per year in health research through the National Institute for Health and Care Research (NIHR). NIHR research expenditure for all cancers was £121 million for 2022/23.</p><p>In terms of establishing targeted funding into pancreatic cancer, the NIHR funds research in response to proposals received from scientists rather than allocating funding to specific disease areas. It is not usual practice to ring-fence funds for particular topics or conditions. Applications are subject to peer review and judged in open competition, with awards made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality.</p><p>The Government, through the NIHR, is committed to improving research into pancreatic cancer and cancers with the poorest survival rates by funding high quality, timely research that leads to improved outcomes for patients and the public, and makes the health and social care system more efficient, effective, and safe. Research evidence is vital for improving treatments and outcomes for people, including those with pancreatic cancer and other less survivable cancers.</p><p>In 2023, the Government awarded £2 million to new interdisciplinary research teams tackling hard to treat cancers, via the Medical Research Council, which hosted a two-day cancer sandpit strategic funding opportunity, focused on technological innovation for understanding cancers with the poorest survival rates.</p><p>The NIHR has funded seven research projects for pancreatic cancer for the period 2019 to 2023, with a total committed spend of approximately £3.6 million. The NIHR also supports the delivery of pancreatic cancer research funded by those in the charity and public sectors. For example, since 2019, the NIHR Clinical Research Network has supported over 70 pancreatic cancer-related studies.</p><p>The NIHR continues to encourage and welcome applications for research into any aspect of human health, including pancreatic cancer. All applications are assessed for funding by peer review committees. The level of research spend in a particular area is driven by factors including the quality of the proposals and their scientific potential. All applications for research into pancreatic cancer and other less survivable cancers made through open competition have been funded.</p> answering member printed Lord Markham grouped question UIN HL3618 question first answered 08/04/2024 11:25:36 answering member 4948 label Biography information for Lord Markham
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1699230

registered interest
date	26/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government when the major conditions strategy will be published.
tabling member printed	Lord Hunt of Kings Heath
uin	HL3620
answer	answer is ministerial correction date of answer 11/04/2024 answer text <p>Our intention is to publish the Major Conditions Strategy in the summer of this year.</p> answering member printed Lord Markham question first answered 11/04/2024 10:53:56 answering member 4948 label Biography information for Lord Markham
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1699231

registered interest
date	26/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS England: Data Protection
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what deficiency in NHS England’s Secure Data Environment was described in paragraph 5.1.10 of the minutes from the 29 February meeting of the Advisory Group for Data, and what steps are being taken to rectify that deficiency.
tabling member printed	Lord Hunt of Kings Heath
uin	HL3621
answer	answer is ministerial correction date of answer 08/04/2024 answer text <p>The point made in the meeting was unrelated to any deficiency within the Secure Data Environment (SDE). The requirement from the Home Office is for specific statistical models and systems to be applied across the dataset requested, which is made up of aggregated data. This specific functionality is available from within the Home Office’s own technical environment, and not from within the SDE. There are no plans at this time to migrate this functionality within the SDE.</p> answering member printed Lord Markham question first answered 08/04/2024 11:26:03 answering member 4948 label Biography information for Lord Markham
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1698279

registered interest
date	25/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Databases
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government further to the Written Answers by Lord Markham on 27 February 2023 (HL5458) and 14 March 2023 (HL5916), whether they will place in the Library of the House a copy of the YAML, R and Python code exportable from NHS England's Federated Data Platform for (1) the Ambulance Dataset Dashboard, and (2) the COVID Monitoring Reporting and Publication Dashboard.
tabling member printed	Lord Hunt of Kings Heath
uin	HL3583
answer	answer is ministerial correction date of answer 05/04/2024 answer text <p>NHS England will from time to time publish examples of code and specifications that are deemed useful to the wider community and industry, including where appropriate, the sharing of code within the NHS GitHub.</p><p> </p><p>To ensure that NHS England is creating a vibrant marketplace for both end users and for industry, it aims to publish the Canonical Data Model structures as well as the metadata, in line with the Tech Code of Practice.</p><p> </p><p>The Federated Data Platform (FDP) Programme is developing a sustainable way to publish examples of specifications and code for specific FDP products. The programme is working through a set of core principles to help determine how they will publish analysis code publicly. This includes making sure that there is appropriate explanatory information surrounding the code, that will help to provide additional context for those viewing the information.</p> answering member printed Lord Markham question first answered 05/04/2024 13:33:02 answering member 4948 label Biography information for Lord Markham
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1698280

registered interest
date	25/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Chronic Fatigue Syndrome: Research
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what progress they have made on the funding of biomedical research into myalgic encephalomyelitis (ME) since the then Parliamentary Under Secretary of State for Health and Social Care stated on 24 January 2019 that “there have not been good enough research proposals in the ME space, partly because of the stigma … and partly because of the division in the medical community”.
tabling member printed	Lord Hunt of Kings Heath
uin	HL3584
answer	answer is ministerial correction date of answer 08/04/2024 answer text <p>The Department funds research through the National Institute for Health and Care Research (NIHR). Since 2019, the NIHR has awarded £1.9 million for research into myalgic encephalomyelitis (ME), also known as chronic fatigue syndrome. The Medical Research Council (MRC), part of UK Research and Innovation (UKRI), has invested £3.6 million since 2019.</p><p>This funding includes the NIHR and UKRI co-funded DecodeME study, a £3.2 million study into the genetic underpinning of ME. The study will analyse samples from 25,000 people with ME, to search for genetic differences that may indicate underlying causes or an increased risk of developing the condition. This study aims to increase our understanding of the disease, and therefore contribute to the research base on diagnostic tests and targeted treatments for ME.</p><p>In 2020, the NIHR, the Chief Scientist Office in Scotland, and the MRC also funded the James Lind Alliance Priority Setting Partnership for ME, facilitated by the charity Action for ME. The report sets out the top 10 research priorities for ME. These recommendations have been co-produced through a process led by a steering group of people living with ME, carers, and clinicians.</p><p>In the interim delivery plan on ME, the Department recognised that there has been a relatively low amount of biomedical research funded on ME, compared with disease burden. The NIHR and MRC welcome applications for further biomedical research into ME. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality. In all disease areas, the amount of funding depends on the volume and quality of scientific activity.</p> answering member printed Lord Markham grouped question UIN HL3585 question first answered 08/04/2024 11:02:22 answering member 4948 label Biography information for Lord Markham
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1697664

registered interest
date	20/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Childbirth
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what progress they have made in implementing the National Maternity Review’s report Better Births, published on 22 February 2016.
tabling member printed	Lord Hunt of Kings Heath
uin	HL3456
answer	answer is ministerial correction date of answer 02/04/2024 answer text <p>The <em>Better Births</em> report sets out a vision for maternity services across England to become safer and more personalised. NHS England subsequently published their <em>Three-Year Delivery Plan for Maternity and Neonatal Services</em>, which sets out how maternity and neonatal care will be made safer, more personalised, and more equitable for women, babies, and families. The plan encompasses recommendations from several reports, including the National Maternity Review’s <em>Better Births</em> report.</p><p>Many initiatives are being delivered through the plan to implement the vision from <em>Better Births</em>, including continuity of carer, rolling out an updated version of the <em>Saving Babies Lives Care Bundle</em> to reduce stillbirth, neonatal brain injury, neonatal death, and preterm birth, and Local Maternity and Neonatal Systems producing Equity and Equality Action Plans to tackle disparities in the outcomes and experiences of maternity care at a local level.</p> answering member printed Lord Markham question first answered 02/04/2024 14:51:12 answering member 4948 label Biography information for Lord Markham
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1697665

registered interest
date	20/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Brain: Tumours
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government whether they will review spending on (1) gliomas, and (2) astrocytoma cancer, to account for any increase in incidences.
tabling member printed	Lord Hunt of Kings Heath
uin	HL3457
answer	answer is ministerial correction date of answer 02/04/2024 answer text <p>The Department invests over £1 billion per year in health research through the National Institute for Health and Care Research (NIHR). The NIHR’s research expenditure for all cancers was £121.8 million in 2022/23. The NIHR spends more on cancer than any other disease group.</p><p>In May 2018 the Government announced £40 million for brain tumour research as part of the Tessa Jowell Brain Cancer Mission through the NIHR. Brain tumours are a difficult research area with a relatively small research community, so we are taking actions to grow the field, such as workshops for researchers, and research training for clinicians. In addition to research programme spend on projects, NIHR research infrastructure supports brain tumour research studies, mainly in the National Health Service. Between 2018 and 2022, UK Research and Innovation, including the Medical Research Council, awarded £23.2 million in brain tumour research funding.</p><p>The Government is committed to improving the survival rates for all cancers. The latest publicly available figures showed improved survival rates across almost all types of cancer, including brain cancer, since 2010. Early diagnosis is key to improving survival rates, and the Department is working towards the NHS Long Term Plan ambition of diagnosing 75% of stageable cancers at stage 1 and 2 by 2028.</p><p>The Government is working jointly with NHS England on implementing the delivery plan for tackling the COVID-19 backlogs in elective care, and plans to spend more than £8 billion from 2022/23 to 2024/25 to help drive up and protect elective activity, including cancer diagnosis and treatment activity.  Over 340,000 people received their first cancer treatment in the 12 months to January 2024.</p> answering member printed Lord Markham grouped question UIN HL3458 question first answered 02/04/2024 14:07:31 answering member 4948 label Biography information for Lord Markham
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1697666

registered interest
date	20/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Brain: Tumours
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what steps they are taking to reduce the adverse disparity in survival rates for brain tumour patients compared to other cancers whose treatment attracts greater levels of funding.
tabling member printed	Lord Hunt of Kings Heath
uin	HL3458
answer	answer is ministerial correction date of answer 02/04/2024 answer text <p>The Department invests over £1 billion per year in health research through the National Institute for Health and Care Research (NIHR). The NIHR’s research expenditure for all cancers was £121.8 million in 2022/23. The NIHR spends more on cancer than any other disease group.</p><p>In May 2018 the Government announced £40 million for brain tumour research as part of the Tessa Jowell Brain Cancer Mission through the NIHR. Brain tumours are a difficult research area with a relatively small research community, so we are taking actions to grow the field, such as workshops for researchers, and research training for clinicians. In addition to research programme spend on projects, NIHR research infrastructure supports brain tumour research studies, mainly in the National Health Service. Between 2018 and 2022, UK Research and Innovation, including the Medical Research Council, awarded £23.2 million in brain tumour research funding.</p><p>The Government is committed to improving the survival rates for all cancers. The latest publicly available figures showed improved survival rates across almost all types of cancer, including brain cancer, since 2010. Early diagnosis is key to improving survival rates, and the Department is working towards the NHS Long Term Plan ambition of diagnosing 75% of stageable cancers at stage 1 and 2 by 2028.</p><p>The Government is working jointly with NHS England on implementing the delivery plan for tackling the COVID-19 backlogs in elective care, and plans to spend more than £8 billion from 2022/23 to 2024/25 to help drive up and protect elective activity, including cancer diagnosis and treatment activity.  Over 340,000 people received their first cancer treatment in the 12 months to January 2024.</p> answering member printed Lord Markham grouped question UIN HL3457 question first answered 02/04/2024 14:07:31 answering member 4948 label Biography information for Lord Markham
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1697667

registered interest
date	20/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Brain: Tumours
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what steps they are taking to ensure that the National Institute for Health and Care Research, the Medical Research Council, and the UK Research and Innovation work together collaboratively to ensure progress on funding brain tumour research.
tabling member printed	Lord Hunt of Kings Heath
uin	HL3459
answer	answer is ministerial correction date of answer 02/04/2024 answer text <p>Research is crucial in tackling cancer, which is why the Department invests over £1 billion per year in health research through the National Institute for Health and Care Research (NIHR). NIHR research expenditure for all cancers was £121.8 million in 2022/23, and the NIHR spends more on cancer than any other disease group.</p><p>In May 2018 the Government announced £40 million for brain tumour research as part of the Tessa Jowell Brain Cancer Mission, through the NIHR. Since this announcement, the NIHR has committed £11.3 million across 17 projects, with the Medical Research Council (MRC) awarding £10.4 million. There is still funding available from the original £40 million, and we expect to spend more as new research progresses.</p><p> </p><p>The Department is taking steps to ensure that funders work closely together to coordinate work along the translational pathway, from the discovery and early translational science typically supported by the MRC, feeding through to the applied health and care research funded by the NIHR. These steps include convening a brain cancer research roundtable in May 2024, to bring together research experts and funders, to determine how to accelerate research efforts in this area.</p><p> </p><p>As an example of coordination, the Efficacy and Mechanism Evaluation (EME) Programme is a partnership between the MRC and the NIHR, supporting research in the mechanisms of diseases, and treatments which have the potential to make a step-change in the promotion of health, treatment of disease, and improvement of rehabilitation or long-term care. The EME’s portfolio includes a £1.5 million clinical trial testing the effectiveness of a targeted form of proton beam radiotherapy for a type of brain cancer called oligodendroglioma. The NIHR also coordinates with the MRC to complement their investments, such as a £2 million investment supporting researchers to understand and treat cancers with exceptionally poor survival rates, including cancer of the brain, lung, and oesophagus.</p> answering member printed Lord Markham question first answered 02/04/2024 13:41:39 answering member 4948 label Biography information for Lord Markham
tabling member	2024 label Biography information for Lord Hunt of Kings Heath